Martin Kršák

960 total citations
40 papers, 609 citations indexed

About

Martin Kršák is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Martin Kršák has authored 40 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 11 papers in Epidemiology and 9 papers in Pharmacology. Recurrent topics in Martin Kršák's work include Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Martin Kršák is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Martin Kršák collaborates with scholars based in United States, Mexico and India. Martin Kršák's co-authors include Matthew A. Miller, Andrés F. Henao‐Martínez, Carlos Franco‐Paredes, Taylor Morrisette, Brian T. Montague, R. Brett McQueen, Gerard R. Barber, Kyle C. Molina, Shanta M. Zimmer and Jamie Solis and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Clinical Orthopaedics and Related Research.

In The Last Decade

Martin Kršák

37 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Kršák United States 13 284 143 110 91 87 40 609
Vivek Kak United States 11 143 0.5× 101 0.7× 53 0.5× 71 0.8× 49 0.6× 42 441
Jacinda C. Abdul‐Mutakabbir United States 16 240 0.8× 135 0.9× 167 1.5× 34 0.4× 27 0.3× 64 735
Mahesh Swaminathan United States 11 304 1.1× 330 2.3× 92 0.8× 21 0.2× 35 0.4× 30 687
Kate R. Woodworth United States 13 559 2.0× 305 2.1× 40 0.4× 441 4.8× 83 1.0× 34 1.6k
Rania M. El-Lababidi United States 10 172 0.6× 97 0.7× 109 1.0× 35 0.4× 38 0.4× 26 563
S Clarke Ireland 20 617 2.2× 428 3.0× 61 0.6× 60 0.7× 64 0.7× 45 976
B. Padilla Spain 17 532 1.9× 520 3.6× 47 0.4× 79 0.9× 91 1.0× 30 979
Birgitta Schweickert Germany 13 188 0.7× 188 1.3× 29 0.3× 34 0.4× 66 0.8× 22 533
Jalal Tarabeia Israel 12 96 0.3× 170 1.2× 56 0.5× 45 0.5× 24 0.3× 25 611
Francesco Vladimiro Segala Italy 11 186 0.7× 108 0.8× 41 0.4× 34 0.4× 33 0.4× 42 489

Countries citing papers authored by Martin Kršák

Since Specialization
Citations

This map shows the geographic impact of Martin Kršák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Kršák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Kršák more than expected).

Fields of papers citing papers by Martin Kršák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Kršák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Kršák. The network helps show where Martin Kršák may publish in the future.

Co-authorship network of co-authors of Martin Kršák

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Kršák. A scholar is included among the top collaborators of Martin Kršák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Kršák. Martin Kršák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kršák, Martin, et al.. (2025). Ketamine-Assisted Group Therapy for Work-Related Stress in First Responders and Frontline Health Care Workers. PubMed. 3(3). 128–135. 1 indexed citations
2.
Kršák, Martin, et al.. (2025). Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium?. Clinical Orthopaedics and Related Research. 483(7). 1225–1233. 3 indexed citations
3.
Kim, Luke, Carlos Franco‐Paredes, Martin Kršák, et al.. (2024). Glucocorticoids as a risk factor for infection and adverse outcomes in non‐HIV and non‐transplant patients with cryptococcal meningitis. Mycoses. 67(3). e13709–e13709. 2 indexed citations
4.
Mueller, Scott W., et al.. (2024). Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. Journal of Burn Care & Research. 45(3). 808–810. 2 indexed citations
5.
Srivastava, Shriyansh, Sachin Kumar, Mahalaqua Nazli Khatib, et al.. (2024). Yellow Fever: Global Impact, Epidemiology, Pathogenesis, and Integrated Prevention Approaches. Infezioni in Medicina. 4(32). 434–450. 8 indexed citations
6.
Shah, Sangam, et al.. (2024). Herpes zoster vaccination and the risk of dementia: A systematic review and meta‐analysis. Brain and Behavior. 14(2). e3415–e3415. 11 indexed citations
7.
Satapathy, Prakasini, Mahalaqua Nazli Khatib, Shilpa Gaidhane, et al.. (2024). Multi-organ clinical manifestations of Mpox: an umbrella review of systematic reviews. BMC Infectious Diseases. 24(1). 992–992. 4 indexed citations
8.
Hileman, Corrilynn O., et al.. (2023). Perceived Risks and Benefits and Frequency of Cannabis Use Among People with HIV in Different Legal Environments. AIDS Research and Human Retroviruses. 40(5). 293–300. 2 indexed citations
9.
Morrisette, Taylor, Kyle C. Molina, Scott W. Mueller, et al.. (2022). Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success. Open Forum Infectious Diseases. 9(6). ofac028–ofac028. 12 indexed citations
10.
Henao‐Martínez, Andrés F., et al.. (2021). COVID-19: a review of current knowledge regarding exposure, quarantine, isolation and other preventive measures. Therapeutic Advances in Infectious Disease. 8. 1998266855–1998266855. 3 indexed citations
11.
Kršák, Martin, et al.. (2021). Benefits of COVID-19 viral screening of formerly incarcerated individuals during community reentry. Therapeutic Advances in Infectious Disease. 8. 4065179999–4065179999. 1 indexed citations
12.
Kršák, Martin, Brian L. Harry, Brent E. Palmer, & Carlos Franco‐Paredes. (2021). Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2. Viral Immunology. 34(8). 504–509. 2 indexed citations
13.
Kršák, Martin, Nikolas Wada, Michael Plankey, et al.. (2020). Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV. Cannabis and Cannabinoid Research. 6(2). 165–173. 6 indexed citations
14.
Kršák, Martin, Andrés F. Henao‐Martínez, & Carlos Franco‐Paredes. (2020). COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies. Viral Immunology. 34(3). 130–133. 1 indexed citations
15.
Franco‐Paredes, Carlos, et al.. (2020). COVID-19 in jails and prisons: A neglected infection in a marginalized population. PLoS neglected tropical diseases. 14(6). e0008409–e0008409. 57 indexed citations
16.
Franco‐Paredes, Carlos, et al.. (2020). Decarceration and community re-entry in the COVID-19 era. The Lancet Infectious Diseases. 21(1). e11–e16. 45 indexed citations
17.
Kršák, Martin, et al.. (2019). Access to Specialty Services: Opportunities for Expansion of Telemedicine to Support Correctional Health Care in Colorado. Telemedicine Journal and e-Health. 26(6). 776–783. 2 indexed citations
18.
Morrisette, Taylor, Matthew A. Miller, Brian T. Montague, et al.. (2019). On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections. Journal of Antimicrobial Chemotherapy. 74(8). 2405–2416. 69 indexed citations
19.
Morrisette, Taylor, Matthew A. Miller, Brian T. Montague, et al.. (2019). Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs. Open Forum Infectious Diseases. 6(7). ofz274–ofz274. 56 indexed citations
20.
Kršák, Martin, David M. Kent, Norma Terrin, et al.. (2015). Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on Statins. AIDS Patient Care and STDs. 29(6). 307–313. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivek Kak Breakdown of academic impact, for papers by Jacinda C. Abdul‐Mutakabbir Breakdown of academic impact, for papers by Mahesh Swaminathan Breakdown of academic impact, for papers by Kate R. Woodworth Breakdown of academic impact, for papers by Rania M. El-Lababidi Breakdown of academic impact, for papers by S Clarke Breakdown of academic impact, for papers by B. Padilla Breakdown of academic impact, for papers by Birgitta Schweickert Breakdown of academic impact, for papers by Jalal Tarabeia Breakdown of academic impact, for papers by Francesco Vladimiro Segala
Rankless by CCL
2026